Benign Prostatic Hyperplasia (BPH)
Definition:
– Benign Prostatic Hyperplasia (BPH) refers to the non-cancerous enlargement of the prostate gland, commonly occurring in older men.
– It is characterized by the proliferation of prostatic cells, leading to the enlargement of the gland and subsequent urinary tract symptoms.
Etiology:
– BPH is primarily influenced by age-related hormonal changes, particularly an increase in dihydrotestosterone (DHT) levels.
– Androgens (testosterone and DHT) and estrogens play a role in the development of BPH.
– Genetic and familial factors also contribute to the risk of developing BPH.
Pathogenesis:
– The prostate gland undergoes changes in cellular structure and composition due to hormonal imbalances.
– These changes lead to the overgrowth of prostatic cells and the formation of nodules within the gland.
– Inflammation and growth factors, such as insulin-like growth factor 1 (IGF-1), contribute to the pathogenesis of BPH.
Clinical Features:
– Lower Urinary Tract Symptoms (LUTS) are the hallmark of BPH and include both voiding and storage symptoms.
– Voiding symptoms: Weak urinary stream, hesitancy, intermittency, straining to urinate, and incomplete emptying.
– Storage symptoms: Increased frequency, urgency, nocturia (waking up at night to urinate), and urinary incontinence.
– BPH can negatively impact a patient’s quality of life, causing discomfort and affecting daily activities.
Investigation:
– Patient history and symptom assessment are crucial for diagnosing BPH.
– Digital Rectal Examination (DRE) helps evaluate the size and consistency of the prostate gland.
– Prostate-Specific Antigen (PSA) blood test measures the level of PSA, which can be elevated in BPH and prostate cancer.
– Imaging studies, such as ultrasound and cystoscopy, aid in assessing prostate size and ruling out other conditions.
– Uroflowmetry measures the rate of urine flow, while post-void residual measurement determines if the bladder empties completely.
Complications:
– Acute Urinary Retention (AUR) occurs when the enlarged prostate obstructs the flow of urine, leading to sudden and painful inability to urinate.
– Recurrent Urinary Tract Infections (UTIs) can occur due to incomplete emptying of the bladder.
– Bladder stones can form as a result of urine stagnation and mineral deposition.
– Bladder diverticula, pouch-like protrusions in the bladder wall, may develop due to increased bladder pressure.
– Severe cases of BPH can lead to renal impairment and kidney damage.
Management:
– Watchful waiting and lifestyle modifications may be recommended for patients with mild symptoms.
– Medications, such as alpha-blockers and 5-alpha reductase inhibitors, can help relieve symptoms and shrink the prostate gland.
– Minimally invasive procedures, like transurethral microwave thermotherapy and laser therapy, are options for moderate BPH.
– Surgical interventions, such as transurethral resection of the prostate (TURP), are considered for severe cases or when other treatments fail.
– Combination therapy, using both medication and surgery, may be required for certain individuals.
– Regular follow-up and monitoring are essential to assess treatment effectiveness and manage any complications.
Note: These brief notes provide an overview of the key points related to BPH. For a comprehensive understanding, further research is therefore recommended